1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • AMC-085: A pilot trial of AVD and brentuximab vedotin in the upfront treatment of stage II-IV HIV-associated Hodgkin lymphoma. A trial of the AIDS malignancy consortium
    Meeting Abstract

    Rubinstein, P. G.; Moore, P.; Henry, D. H.; Ratner, L.; Sharon, E.; Noy, A.
    Blood (2015)

    Fulltext@MSK | Save
  • Toxicity of maintenance rituximab in older adults with non-Hodgkin lymphoma
    Meeting Abstract

    Matasar, M. J.; Atoria, C. L.; Elkin, E. B.; Nabhan, C.
    Blood (2015)

    Fulltext@MSK | Save
  • TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up
    Meeting Abstract

    Horwitz, S. M.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R.; Pro, B.; Chen, R.; Davies, A. J.; Illidge, T.; Huebner, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Ibrutinib plus rituximab in treatment-naive patients with follicular lymphoma: Results from a multicenter, phase 2 study
    Meeting Abstract

    Fowler, N.; Nastoupil, L.; de Vos, S.; Knapp, M.; Flinn, I. W.; Chen, R.; Advani, R. H.; Bhatia, S.; Martin, P.; Mena, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): Sub-analysis of SWOG S0816 phase 2 trial
    Meeting Abstract

    Danilov, A. V.; Li, H. L.; Press, O. W.; Shapira, I.; Swinnen, L. J.; Noy, A.; Reid, E.; Smith, S. M.; Friedberg, J. W.
    Blood (2015)

    Fulltext@MSK | Save
  • Risk-adapted therapy in adults with Burkitt lymphoma: Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
    Meeting Abstract

    Dunleavy, K.; Noy, A.; Abramson, J. S.; LaCasce, A. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P. J.; Mitsuyasu, R. T.; Battini, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • BET inhibitor CPI-0610 is well tolerated and induces responses in diffuse large B-cell lymphoma and follicular lymphoma: Preliminary analysis of an ongoing phase 1 study
    Meeting Abstract

    Abramson, J. S.; Blum, K. A.; Flinn, I. W.; Gutierrez, M.; Goy, A.; Maris, M.; Cooper, M.; O'Meara, M.; Borger, D.; Mertz, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High-depth, targeted, next generation sequencing identifies novel genetic alterations in cutaneous T-cell lymphoma
    Meeting Abstract

    Argyropoulos, K. V.; Horwitz, S. M.; Rapaport, F.; Velardi, E.; Myskowski, P.; Querfeld, C.; Pulitzer, M.; Dogan, A.; Gallagher, M.; Socci, N. D.; more...
    Blood (2015)

    Fulltext@MSK | Save